New England Section of the American Urological Association

NEAUA Home NEAUA Home Past & Future Meetings Past & Future Meetings

Back to 2024 Abstracts


Assessing the safety of ureteral stent placement for obstructive urolithiasis in patients during the covid-19 pandemic
Ankur Ushir Choksi, MD, Soum D. Lokeshwar, MD, Mursal Gardezi, MD, Christopher S. Hayden, MD, Timothy Tran, MD, Dinesh Singh, MD, Piruz Motamedinia, MD, Thomas V. Martin, MD.
Yale School of Medicine, New Haven, CT, USA.

BACKGROUND: Patients with an active SARS-CoV-2 infection are at a higher risk of post-operative mortality as well as pulmonary and cardiovascular complications. In this study, we analyze the post-operative safety of patients undergoing cystoscopy with ureteral stent placement for an obstructing ureteral calculi that tested positive for COVID-19.
METHODS: We retrospectively identified patients who underwent cystoscopy and ureteral stent placement between June 5, 2020 and December 31, 2022 as an add-on case after presenting to the Emergency Department. Patients were stratified by whether they had a positive COVID-19 test on admission. Baseline characteristics were compared using Students t-test for continuous variables and Pearson chi-square test for categorical variables. Univariate and multivariate logistic regression analysis was performed to identify predictors of postoperative 30-day mortality.
RESULTS: A total of 1,408 patients underwent add-on cystoscopy with ureteral stent placement for an obstructing calculus, of which 55 (3.9%) patients had a positive COVID-19 test. When stratified by COVID-19 status, both groups were similar with regards to age, sex, race, co-morbidities, indications, procedure duration, and type of anesthesia administered (Table 1). Patients without COVID-19 had a higher prevalence of chronic lung disease. Of the 137 patients that were admitted to the ICU, 9 patients were COVID-19 positive (16.4% vs. 9.4%, p = 0.09). On multivariate logistic regression, patients with COVID-19 had a higher odds of 30-day mortality (OR 7.06, 95% CI: 2.03 - 24.47, p = 0.002) when controlling for age, co-morbidities, vaccination status, anesthesia type, and indication for the stent (Table 2).
CONCLUSIONS: Patients that underwent cystoscopy and ureteral stent placement for an obstructing ureteral stone with a concurrent COVID-19 diagnosis had an increased risk of perioperative 30-day mortality. It is unclear how this fares to patients with COVID-19 who were diagnosed with a ureteral stone and did not undergo ureteral stent placement.


Back to 2024 Abstracts